Analyst firms · Morgan Stanley · CTLT

Morgan Stanley CTLT price target and rating history

Catalent Inc. (CTLT) · Health Care

Morgan Stanley rates Catalent Inc. (CTLT) Overweight with a $145 price target, as of its latest action on Feb 2, 2022. It has published 3 rating actions on CTLT since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$145
Median target, all firms
Too few
Actions on CTLT
3

Morgan Stanley price target on CTLT

$160$153$14520222023202420252026
Morgan Stanley price target on CTLT, each point a stated target, August 2021 to February 2022.

Every Morgan Stanley rating on CTLT

Questions about Morgan Stanley and CTLT

What is Morgan Stanley's price target for CTLT?
Morgan Stanley's latest stated price target for Catalent Inc. (CTLT) is $145, from its action on Feb 2, 2022.
What is Morgan Stanley's rating on CTLT?
Morgan Stanley rates CTLT Overweight, a bullish rating, as of Feb 2, 2022.
When did Morgan Stanley last change its view on CTLT?
On Feb 2, 2022, Morgan Stanley cuts its price target to $145 from $160, keeps Overweight.

More CTLT rating histories

All Morgan Stanley ratingsCTLT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.